Biomarin Pharmaceutical Inc
XMUN:BM8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biomarin Pharmaceutical Inc
XMUN:BM8
|
US |
|
G
|
Gilead Sciences Inc
XMUN:GIS
|
US |
|
S
|
Schlumberger NV
F:SCL
|
US |
|
Uniti Group Ltd
ASX:UWL
|
AU |
|
E
|
Emerita Resources Corp
F:LLJA
|
CA |
|
S
|
Severn Trent PLC
F:SVT1
|
UK |
|
P
|
Pembina Pipeline Corp
NYSE:PBA
|
CA |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
SWB:BBVA
|
ES |
|
Barings BDC Inc
NYSE:BBDC
|
US |
|
T
|
TAL Education Group
SWB:IZZ
|
CN |
|
E
|
Electricite de France SA
F:E2F
|
FR |
|
U
|
United Rentals Inc
F:UR3
|
US |
|
D
|
Danaher Corp
DUS:DAP
|
US |
|
S
|
Sumitomo Corp
F:SUMB
|
JP |
|
C
|
Coca-Cola Co
XMUN:CCC3
|
US |
|
I
|
Italtile Ltd
JSE:ITE
|
ZA |
|
D
|
D R Horton Inc
F:HO2
|
US |
|
H
|
Henkel AG & Co KGaA
SWB:HEN3
|
DE |
|
U
|
Uber Technologies Inc
F:UT8
|
US |
|
F
|
Fluor Corp
XMUN:FLU
|
US |
|
G
|
Globe Life Inc
F:TMJ
|
US |
|
C
|
China Shenhua Energy Co Ltd
SWB:IKF
|
CN |
|
Swiss Re AG
SIX:SREN
|
CH |
Bankruptcy Probability
Biomarin Pharmaceutical Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Biomarin Pharmaceutical Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
12.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
456.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
236.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Biomarin Pharmaceutical Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Biomarin Pharmaceutical Inc has total debt of 3.5B USD. This includes both short-term (0 USD) and long-term (3.5B USD) debt.
You can find a full breakdown on its Balance Sheet.
